RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-17.44%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$3.87B
AUM Growth
+$3.87B
(-20%)
Cap. Flow
+$304M
Cap. Flow
% of AUM
7.85%
Top 10 Holdings %
Top 10 Hldgs %
45.33%
Holding
116
New
10
Increased
28
Reduced
12
Closed
9
Top Buys
| 1 |
Immunocore
IMCR
|
$79.7M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$59.5M |
| 3 |
argenx
ARGX
|
$40M |
| 4 |
Thermo Fisher Scientific
TMO
|
$34M |
| 5 |
Masimo
MASI
|
$29.2M |
Top Sells
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$32M |
| 2 |
Globus Medical
GMED
|
$31.5M |
| 3 |
Athira Pharma
ATHA
|
$25.7M |
| 4 |
iTeos Therapeutics
ITOS
|
$15.7M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$14M |
Sector Composition
| 1 | Healthcare | 98.86% |
| 2 | Financials | 0.75% |
| 3 | Industrials | 0.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tandem Diabetes Care
TNDM
$845M
| $54.6M | 1.41% | 922,630 -82,306 | -8% | -$4.87M |
|
27
Relmada Therapeutics
RLMD
$37.2M
| $50.1M | 1.29% | 2,637,581 +97,507 | +4% | +$1.85M |
|
28
Stoke Therapeutics
STOK
$1.08B
| $48.2M | 1.25% | 3,651,823 +7,575 | +0.2% | +$100K |
|
29
Regenxbio
RGNX
$451M
| $45.6M | 1.18% | 1,845,366 | – | – |
|
30
10x Genomics
TXG
$1.74B
| $43.4M | 1.12% | 959,481 +225,000 | +31% | +$10.2M |
|
31
Protagonist Therapeutics
PTGX
$3.67B
| $37.9M | 0.98% | 4,794,499 | – | – |
|
32
Guardant Health
GH
$8.41B
| $37.3M | 0.96% | 924,887 +235,000 | +34% | +$9.48M |
|
33
Quanterix
QTRX
$211M
| $29.5M | 0.76% | 1,819,120 +570,603 | +46% | +$9.24M |
|
34
Tarsus Pharmaceuticals
TARS
$2.47B
| $29.4M | 0.76% | 2,013,601 | – | – |
|
35
Milestone Pharmaceuticals
MIST
$156M
| $26.5M | 0.69% | 4,315,102 | – | – |
|
|
CINC
36
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $26.2M | 0.68% | 1,389,705 | – | – |
|
37
Veru
VERU
$47.6M
| $25.1M | 0.65% | +2,220,983 | New | +$25.1M |
|
|
OLK
38
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $23.7M | 0.61% | 1,562,222 +544,034 | +53% | +$8.27M |
|
39
C4 Therapeutics
CCCC
$185M
| $23.3M | 0.6% | 3,094,825 -1,437,157 | -32% | -$10.8M |
|
40
GH Research
GHRS
$837M
| $21.6M | 0.56% | 2,168,957 | – | – |
|
|
BCYC
41
Bicycle Therapeutics
BCYC
$511M
| $21.4M | 0.55% | 1,276,276 | – | – |
|
42
Castle Biosciences
CSTL
$696M
| $20.1M | 0.52% | 913,789 +417,114 | +84% | +$9.16M |
|
43
Apyx Medical
APYX
$75.3M
| $19.9M | 0.51% | 3,398,279 | – | – |
|
44
Fulcrum Therapeutics
FULC
$351M
| $19.4M | 0.5% | 3,961,194 +350,000 | +10% | +$1.72M |
|
45
Ventyx Biosciences
VTYX
$171M
| $19M | 0.49% | 1,551,778 | – | – |
|
|
DMTK
46
DELISTED
DermTech, Inc. Common Stock
DMTK
| $17.3M | 0.45% | 3,118,666 | – | – |
|
|
TSVT
47
DELISTED
2seventy bio
TSVT
| $16.2M | 0.42% | 1,229,508 | – | – |
|
|
AVDL
48
Avadel Pharmaceuticals
AVDL
$1.43B
| $14M | 0.36% | 5,741,939 | – | – |
|
49
Tenaya Therapeutics
TNYA
$184M
| $13.8M | 0.36% | 2,458,750 | – | – |
|
50
Outset Medical
OM
$247M
| $13.5M | 0.35% | 909,652 +10,000 | +1% | +$149K |
|